Rigel Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RIGL and other ETFs, options, and stocks.About RIGL
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.
CEORaul R. Rodriguez
CEORaul R. Rodriguez
Employees164
Employees164
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded1996
Founded1996
Employees164
Employees164
RIGL Key Statistics
Market cap926.63M
Market cap926.63M
Price-Earnings ratio8.26
Price-Earnings ratio8.26
Dividend yield—
Dividend yield—
Average volume693.95K
Average volume693.95K
High today$51.73
High today$51.73
Low today$49.23
Low today$49.23
Open price$50.52
Open price$50.52
Volume470.26K
Volume470.26K
52 Week high$51.73
52 Week high$51.73
52 Week low$14.63
52 Week low$14.63
Stock Snapshot
The current Rigel Pharmaceuticals(RIGL) stock price is $50.25, with a market capitalization of 926.63M. The stock trades at a price-to-earnings (P/E) ratio of 8.26.
On 2025-11-27, Rigel Pharmaceuticals(RIGL) stock moved within a range of $49.23 to $51.73. With shares now at $50.25, the stock is trading +2.1% above its intraday low and -2.9% below the session's peak.
Trading volume for Rigel Pharmaceuticals(RIGL) stock has reached 470.26K, versus its average volume of 693.95K.
The stock's 52-week range extends from a low of $14.63 to a high of $51.73.
The stock's 52-week range extends from a low of $14.63 to a high of $51.73.
People also own
Based on the portfolios of people who own RIGL. This list is generated using Robinhood data, and it’s not a recommendation.